WEDNESDAY, Aug. 7, 2019 — There’s nothing more embarrassing than sweating profusely in public places, yet one expert says many people suffer through the humiliation for decades. At least 15 million people in the U.S. have excessive sweating (hyperhidrosis), according to the American Academy of Dermatology (AAD). Yet, half of people with the condition delay… Read More »
Major depression, obesity and chronic pain are all linked to the effects of one protein, called “FK506-binding protein 51,” or FKBP51. Until now, efforts to inhibit this target have been hampered by the difficulty of finding something specific enough to do the job and not affect similar proteins. Now a research group has developed a… Read More »
Print this page ALAMEDA, Calif.–(BUSINESS WIRE)–Jan. 14, 2019– Exelixis, Inc. (NASDAQ:EXEL) today announced that the U.S. Food and Drug Administration (FDA) approved Cabometyx (cabozantinib) tablets for patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib. HCC is the most common form of liver cancer and the fastest-rising cause of cancer-related death in… Read More »
One of its prime sources of water is the Rio Grande. Typically the river can supply as much as half of the city’s water needs. But climate change is making that increasingly difficult and is pushing the city to look for new sources of water. Now, El Paso is on track to become the first… Read More »
If you’ve suffered with severe atopic dermatitis (eczema) for a long time and have tried what you think is every available option for relief, you may want to consider allergy shots. A medically-challenging case being presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting found that allergy shots provided significant… Read More »